The future of digital health, including the potential of genomic big-data in healthcare, becomes possible only through the patient.
(PRWEB) October 07, 2015
Gliimpse - a Silicon Valley start-up and the world’s first automated Personal Health Data platform allowing any U.S. individual to collect, personalize and share a picture of their health data launches in beta today, being selected as one of ten finalists in the prestigious Health 2.0 Conference Launch! competition. Founded on a single core notion, Gliimpse believes that everyone should be able to collect and securely share their personalized health data with whomever they trust - all 317 million U.S. citizens.
Gliimpse will accept new user requests starting today. Anyone interested in getting a free Gliimpse Profile can sign-up and request an invite at Gliimpse's website.
Patient-Mediated Data Portability solves EMR Interoperability Without violating HIPAA
“The future of digital health, including the potential of genomic big-data in healthcare, becomes possible only through the patient,” notes Anil Sethi, Founder of Gliimpse and a five-time healthcare entrepreneur. “The health-IT industry currently has a decade long goal of cracking electronic medical record (EMR) system interoperability. Instead, Gliimpse has shown that a more pragmatic solve to interoperability is patient-mediated data portability. Patients don’t want all their clinical details siloed away in a hospital’s EMR. Folks just need a glimpse into their health (pun intended), so they can use Gliimpse to collect, curate and share their personal health stories with professionals and family, or even to pay it forward and donate their anonymized data to accelerate cures.”
Software, not Services, Delivers Instantaneous Data and Valuable Insights
Gliimpse’s value results from the software-driven automation of its patient data pipeline. A series of computational algorithms, sequenced into a data refining pipeline, this technology allows users to collect data and share snapshots of their health information, moving from siloed patient portals to a personalized longitudinal health profile. This all happens instantly since Gliimpse is a product outputting computational data, versus a service reliant on manually collected paper records.
As a Data-as-a-Service (DaaS) platform, Gliimpse allows users to immediately graph trends and have a sense of ownership around their health, with the ability to combine fragmented health data from disparate clinical systems and personalize their health profile with patient reported outcomes (PROs). Gliimpse's pipeline codes data elements according to fine-grained federal and industry standards. Users can then easily search all their data, plus view “outliers” that lets them and their physicians trend abnormal labs, scanning hundreds of records. Researchers will eventually search across anonymously donated profiles, finding life-saving insights that will accelerate cures.
Dedicated Team with Track Record of Eight Startups
Sethi recently gave a scintillating talk at the prestigious Stanford Medicine X conference that offered a glimpse into the company’s far-reaching data platform vision. Gliimpse’s co-founder and President, Karthik Hariharan will also showcase the product in a live demo at Health 2.0 in Santa Clara on Oct 7 where Gliimpse has been nominated as one of ten finalists in the event’s Launch! competition.
Together, the duo are veterans of eight startups and have self-funded Gliimpse for the past eighteen months. Combined, they have three exits approximating $400M, an IPO, and as Hariharan quips, “this ain't our first rodeo.”
Register for Gliimpse today during the limited time FREE beta by signing up at Gliimpse.
A healthy future is only a Gliimpse away.
For more Information, contact:
Anil Sethi, Founder